START TYPING AND PRESS ENTER TO SEARCH

    Receive this Monthly Publication in your Inbox

    Never miss the latest in Healthcare Performance Insider by subscribing HERE!

    @Copyright 2019 - Healthcare Performance Insider a publication from Accumen, Inc

    Where should we send your newsletter?

    Privacy Policy: We hate spam and promise to keep your email address safe

    Mike Hostetler

    How Imbio is using AI to close the gap of missed diagnosis with Mike Hostetler

    Global Impact: Rebecca Rock, RN and SABM CFO talks with HPI about two roles across two countries

    From Lab Trend Visionary to Dark Group CEO: HPI connects with the Founder and Editor of the Dark Report, Robert Michel

    Two Imaging Leaders, Two Systems, One Outcome: Communication

    From Communication Strength to Just in Time Reopening at MGH A conversation with Dr. James Brink, Chief of Radiology at Massachusetts General Hospital

    From Time Magazine to PBM Influencer: Sherri Ozawa's Mission to Define the Value of Blood

    Buried Blessings: Pandemic perspective from Tom Strauss, CEO at Sisters of Charity Health System

    Katie Castree, Career Healthcare Process Improvement Connoisseur

    Solving Lab Challenges through Recruiting Innovation: HPI connects with Lighthouse Lab Services President, Jon Harol

    Providing Value-Based Care in a Pandemic through Telehealth and Data Resources: An HPI exclusive with Dr. Darrel Weaver

    From Supply Chain Crisis to Innovation in a Pandemic

    From Navy Medic to running a Clinical Laboratory . . . during a pandemic

    Planning for Blood Shortages in a Pandemic with Dr. Claudia Cohn

    Blood Banking is more complex today than ever before. Rob Van Tuyle, President of Vitalant's Blood Division, tells us why.

    Profoundly Impacting Healthcare with Breakthrough Anemia Management

    Supporting Imaging Precisely Where You Need It

    Working Together Makes End of Life Conversations Easier to Have

    The Future of Imaging: Assessing the early impacts of COVID-19 and the path to innovation through Artificial Intelligence (AI) A conversation with Dr. Geoff Rubin

    Pivoting in a Pandemic: How a U.S. 3D printing manufacturer is helping healthcare in its time of need

    Mara G. Aspinall: Diagnostic evangelist educating the world on the power of diagnostics today

    How The Joint Commission is addressing the COVID-19 Pandemic

    CHI Nebraska’s Laboratory Director Connie Wilkins, describes How To Manage a Clinical Laboratory During the pandemic

    Former Commercial Lab Leader Highlights the Hospital Lab as the Solution to Community Sustainability in a Healthcare Crisis

    Three Phases Essential to Crisis Preparedness in Patient Blood Management with Anne Burkey of St. Luke's Health in Boise, ID

    The Importance of Agility in Your Lab

    Dr. Paul Biddinger Shares Three Ways to Prepare for COVID-19

    Bringing Clinical Skills to Operational Leadership During a Time of Crisis; Dr. Blanton, Chief Medical Officer at Peterson Health

    7 Team Attributes to Teams that Work in Challenging Times & Through Rapid Innovation

    From Finding Problems to Saving Lives: The Evolution of Interventional Radiology

    Identifying the Potential with AI in Radiology with Dr. Chung

    Communication in the C-Suite with Cliff Robertson of Catholic Health Initiatives

    Reviewing Your Patient Financial Journey with Melody W. Mulaik, President of Revenue Cycle Coding Strategies

    Ask An Accumen Expert: Carolyn Burns, MD, a Patient Blood Management Advocate

    Linda DeVee, Leads Radiology Services at Edward-Elmhurst Health

    Theresa Mouton, Market Chief Financial Officer with Steward Health

    PELITAS President and CEO Steven Huddleston Wants Patients to Have a Great Experience – Both Clinically and Financially

    How Do You Deal with 2 Billion Forms a Year? Ask Randy Campbell

    Medical Director of Telehealth for UAB Knocks Barriers Down to Treat Patients on Their Terms

    C-Suite Spotlight: Wayne Bohenek Chief Ancillary Services Officer, Bon Secours Mercy Health

    A Leader in the Laboratory Service Line : Pierre Mouawad

    Healthcare Partner: Autumn Farmer, Chief Laboratory Officer, Bon Secours Mercy Health

    How Imbio is using AI to close the gap of missed diagnosis with Mike Hostetler

    Spit Matters with Bill Phillips from Spectrum Solutions

    How COVID-19 inspired TeraRecon to accelerate their imaging solutions to the point of care with Jeff Sorensen

    Mike Hostetler lost his father when he was 13 to pancreatic cancer. Admittedly curious as to what happened and the cause of his father’s disease, he set his sights on medical school. During his early studies, a retired surgeon gave him some advice that changed his course: “Stay out of medicine. You can do more good by going into business.” So Mike got a business degree and went into the medical device space, having successfully launched over 50 products in his 25 year career, inherently focused on working with products that can ultimately change the course of experiences like he had as a kid. Today this work is in artificial intelligence, with Imbio, as the Director of Sales and Marketing.

    Who is Imbio?
    Imbio uses artificial intelligence to look at different patterns or anomalies in medical images, primarily focusing on CT scans of the chest. Their software essentially trains computers to recognize diseases that humans have previously determined to be present in patients with that specific disease, using thousands of patient scans, to help radiologists find diseases that are difficult to see with the human eye. They personalize each image for that patient and that treating physician, transforming standard images into rich visual maps with quantitative reports. This level of detailed data on the type and extent of present abnormalities helps physicians develop a treatment plan specifically for that patient.

    If we have AI, do we need Radiologists?
    Yes! Mike is adamant to drive this point home, noting that when artificial intelligence first hit the scene at an RSNA conference there was a lot of hype around it, including fear and doubt about whether it would replace radiologists. The reality is, it’s just another tool in the physician toolbox.

    The radiologist is the mechanic. We’re just giving them a new wrench – a really nice wrench. In Imbio’s case, the wrench looks at chest CTs for chronic and some acute diseases. Over the last couple of years there’s been this sigh of relief because there is a radiologist shortage globally. AI is helping them become much more efficient. Some studies have shown efficiency to be more than 30%. Now, it’s up to the radiologist to choose which algorithms and AI technologies they want to deploy to keep the momentum going.

    Leaning in with industry partners
    While consumer products are adopted in minutes (iPhone 12 anyone? Oh sorry, it’s been out for 2 weeks and they’re sold out everywhere), healthcare has significant constraints. It’s heavily regulated because we’re working with people on top of minuscule profit margins.

    Mike notes that the primary roadblock in many countries is not the radiologist but the IT and security systems within the hospital. They have their own data centers; new systems and technology like Imbio mean there will be some upfront cost as in people resources – neither of which is readily available anywhere in healthcare today.

    A single integration can take over a year to install simply because of the proverbial red tape.

    How many patients are missed during that time?
    Mike points to IT as the main roadblock in integrating with hospitals and health systems. Highlighting an example that has currently been delayed 9 months from doing a 90-day trial just because the IT systems can be so slow. With a perpetual focus on solutions, Mike highlights the value of channel partners in cutting through delays. Working with an external partner that has already cut their teeth in the space and made it through the red tape and security gauntlet, allows higher levels of imaging to be used in a matter of weeks versus years.

    The partnership model with companies like 3DR Labs has allowed Imbio to expand fast, with the potential to deploy AI technology in 70 countries and thousands of providers. And we’re just getting started.

    Now that we’ve got these channel partners, we’re freed up to do the things that we want to do – build algorithms. We’ve got six or seven algorithms in development.  We’re going to stick to our lung and cardiothoracic space, because there’s a lot of disease there that needs artificial intelligence to help. And we owe all that to our channel partners. No question.

    Closing the gap
    There are big health systems across the globe that admittedly miss patients with disease. In radiology, it can be from the sheer number of chest CTs on a daily basis. They can’t all be treated and there is no historical software failsafe. Patients unfortunately slip through the cracks. Sadly, when patients slip through the cracks, they go home, they can be okay for a year or two, then come back with exacerbations. It costs the health system more money – on top of potential fines from CMS. AI solutions, like Imbio, can help screen and catch patients who can benefit from early stage disease treatment.

    In October 2020, MIT released survey results from 900 health professionals showing that 64% have either deployed or evaluated medical imaging AI. That means hundreds of hospitals across the US have deployed some form of AI in medical imaging, for use in everything from triage cases (like intracranial hemorrhages and pulmonary embolisms) to broader chronic diseases (like COPD and emphysema).

    AI in the hands of radiologists and treating physicians together is truly personalized medicine. The increased collaboration and use of quantitative data I’ve seen firsthand has been just fantastic.

    Imbio and other AI companies are influencing that, and it’s just fun to watch.

    Imbio is improving healthcare by increasing the number of patients that can be treated and removing an additional burden of cost in missed diagnosis. That’s a pretty profound impact. It looks like that surgeon was right Mike. You’ve done good!

     
    Mike Hostetler

    Mike Hostetler

    Director of Marketing & Sales, Imbio